Session 503: Chair's Introduction (pdf, 1024КБ)
08:30-10:30, October 27th, 2016 (Thursday)
Place: Changi Room 1, 4th Floor

BIT’s 6th Annual World Congress of Nano-S&T 2016
Theme: Small is All, The Future of Nanotechnology

Dr. Peter I Belobrov*, Anton S Yakimov, Ivan A Denisov, Kirill A Lukyanenko, Elena N Esimbekova, and Anatoly A Evstrapov. Luciferase-Based Microfluidic Platform for Point of Care Testing and Nanomedicine Applications // Conference Abstract Book Nano-S&T 2016, p. 436.

Abstract (pdf, 151КБ)

Presentation (pdf, 2115КБ)

Brittany L. Banik, Pouria Fattahi, and Justin L. Brown. Polymeric nanoparticles: the future of nanomedicine // Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 8, no. 2 (2016): 271-299.

Shuming Nie. "Understanding and overcoming major barriers in cancer nanomedicine // Nanomedicine 5, no. 4 (2010): 523-528. Cited by 161

Volker Wagner, Anwyn Dullaart, Anne-Katrin Bock, and Axel Zweck. The emerging nanomedicine landscape // Nature biotechnology 24, no. 10 (2006): 1211-1217. Cited by 996

Rakesh K. Jain, and Triantafyllos Stylianopoulos. Delivering nanomedicine to solid tumors // Nature reviews Clinical oncology 7, no. 11 (2010): 653-664. Cited by 1116

Didier Astruc, Elodie Boisselier, and Catia Ornelas. Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine // Chemical Reviews 110, no. 4 (2010): 1857-1959. Cited by 1099

Scholar Google "Nanomedicine" ~ results 196 of 2017; 22,500 of 2016;

WIREs Nanomedicine and Nanobiotechnology
Current Issue: November/December 2016 Volume 8, Issue 6

Int J Nanomedicine 影响因子
Recent Volume 11, 2016 (401)
Endorsed by the American Society for Nanomedicine

Nanomedicine
Current Issue View Volume 11, Issue 20 (2016)

Nanomedicine: Nanotechnology, Biology and Medicine
Open Access
Recent Volume 12, Issue 8, In Progress (November 2016)

Wendy R. Sanhai, Jason H. Sakamoto, Richard Canady, and Mauro Ferrari. Seven challenges for nanomedicine // Nature nanotechnology 3, no. 5 (2008): 242-244. Cited by 291
Nanomedicine offers new opportunities to fight diseases but a global effort is needed to safely translate laboratory innovation to the clinic. Seven priority areas have been identified for this endeavour.

Pedro M. Valencia, Omid C. Farokhzad, Rohit Karnik, and Robert Langer. Microfluidic technologies for accelerating the clinical translation of nanoparticles // Nature nanotechnology 7, no. 10 (2012): 623-629. Cited by 168

Shaurya Prakash, Aigars Piruska, Enid N. Gatimu, Paul W. Bohn, Jonathan V. Sweedler, and Mark A. Shannon. Nanofluidics: systems and applications // IEEE Sensors Journal 8, no. 5 (2008): 441-450. Cited by 73

YongTae Kim, and Robert Langer. Microfluidics in Nanomedicine // Reviews in Cell Biology and Molecular Medicine (2015).

Nathan M. Belliveau, Jens Huft, Paulo JC Lin, Sam Chen, Alex KK Leung, Timothy J. Leaver, Andre W. Wild et al. Microfluidic synthesis of highly potent limit-size lipid nanoparticles for in vivo delivery of siRNA // Molecular Therapy—Nucleic Acids 1, no. 8 (2012): e37. Cited by 110 Keywords: lipid nanoparticle; microfluidics; nanomedicine; siRNA; synthesis and formulation.

Dias Ricardo Rui Lima, Antonio A. Martins, Teresa M. Mata, Jacinto Sá, Cristina-Elena Stere, Alexandre Goguet et al. Single and two-phase flows on chemical and biomedical engineering. 2012. "Growing areas such as microfluidics, nanomedicine and the modelling and simulation of complex flow in living systems such as the blood flow in microvascular networks rely upon a good description of the flow."